Bryan Curtin, MD
Gastroenterology · Augusta, GANPI 1437425873
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $59,526 of the $81,960 with a category attached, or 72.6%. Ardelyx, Inc. accounts for 70.1% of it on its own, with 34 other manufacturers making up the rest. 2025 is the largest year on record at $56,298, more than ten times the $78 reported in 2020. Among gastroenterology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 354 payments — averaging $231.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ardelyx, Inc.$57K
- AbbVie$20K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- QOL Medical, LLC$477
- Vibrant Gastro, Inc.$393
- Medtronic$313
- plus $2K from 29 others
What the payments were for
- Consulting fees$11,25014%
- Speaking & faculty fees$59,52673%
- Travel & lodging$2,8293%
- Food & beverage$8,35610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ardelyx, Inc. | 88 | $57,415 |
| AbbVie | 88 | $20,274 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 66 | $1,130 |
| QOL Medical, LLC | 20 | $477 |
| Vibrant Gastro, Inc. | 2 | $393 |
| Medtronic | 4 | $313 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $286 |
| Enterra Medical, Inc. | 2 | $205 |
| Mallinckrodt Hospital Products Inc. | 7 | $177 |
| Aimmune Therapeutics, Inc. | 5 | $132 |
| Intercept Pharmaceuticals, Inc. | 6 | $122 |
| Alnylam Pharmaceuticals Inc. | 7 | $113 |
| Ironwood Pharmaceuticals, Inc | 6 | $106 |
| Exelixis Inc. | 3 | $86 |
| Phathom Pharmaceuticals, Inc. | 3 | $67 |
| Sanofi | 3 | $67 |
| Nestle Healthcare Nutrition Inc. | 4 | $62 |
| Cumberland Pharmaceuticals, Inc. | 3 | $60 |
| Eisai Inc. | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Teleflex LLC | 2 | $43 |
| Bristol Myers Squibb | 2 | $41 |
| Braintree Laboratories, Inc. | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $36 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Lilly USA, LLC | 1 | $27 |
| Evoke Pharma, Inc. | 2 | $26 |
| Ipsen Biopharmaceuticals, Inc | 1 | $26 |
| Redhill Biopharma Inc. | 1 | $20 |
| Gilead | 1 | $19 |
| Laborie Medical Technologies Corp. | 1 | $19 |
| AstraZeneca | 1 | $18 |
| Amgen | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Digestive Care, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$81,960 in reported general payments places this provider in the 95th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IbsrelaTenapanor Hcl | 50 | $124,108 |
| LinzessLinaclotide | 95 | $110,574 |
| XifaxanRifaximin | 42 | $96,371 |
| MotegrityPrucalopride Succinate | 71 | $65,396 |
| ViberziEluxadoline | 11 | $24,731 |
| Dexlansoprazole DrDexlansoprazole | 24 | $10,456 |
| Sucralfate | 73 | $5,947 |
| Pyridostigmine Bromide | 38 | $5,760 |
| Scopolamine | 62 | $5,452 |
| Mirtazapine | 109 | $5,180 |
| Dicyclomine Hcl | 112 | $2,791 |
| Esomeprazole Magnesium | 38 | $2,712 |
| Amitriptyline Hcl | 139 | $2,271 |
| Diphenhydramine Hcl | 14 | $2,229 |
| Lactated RingersRinger's Solution,lactated | 34 | $2,022 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Viberzi | $20,274 | $135,306106 claims |
| Ardelyx, Inc.Ibsrela | $57,415 | $124,10850 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $1,130 | $96,37142 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $286 | $65,39671 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 492 gastroenterology providers in Georgia.
Other gastroenterology in Augusta
- Satish RaoAugusta$335K
- Kenneth VegaAugusta$59K
- Sunil LalAugusta$26K
- Nitin GuptaAtlanta$1.1M
- Cynthia RudertAtlanta$720K
- Douglas WolfAtlanta$668K
- Kavita KongaraAtlanta$492K
- Girish AnandAtlanta$425K
- Roshan ShresthaAtlanta$317K
- Hetal KarsanAtlanta$314K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.